Clinical Trials Directory

Trials / Completed

CompletedNCT04174625

The Effect of Omega 3 on 25 Hydroxyvitamin D

The Effect of Omega 3 Supplementations on Serum 25 Hydroxyvitamin D Levels

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Applied Science Private University · Academic / Other
Sex
All
Age
22 Years – 66 Years
Healthy volunteers
Accepted

Summary

The effect of omega 3 fatty acid on serum 25-hydroxyvitamin D levels.

Detailed description

No data are available on the effect of omega 3 on serum 25-hydroxyvitamin D levels in Jordanian men and women. This study was designed to investigate whether omega 3 supplementation has a potential effect on the reducing of serum 25-hydroxyvitamin D levels. This randomized, placebo-controlled clinical trial (RCT) was designed to evaluate 300 mg omega-3FA daily for 2 months on serum levels of 25-hydroxyvitamin D levels. This RCT will be conducted on 80 to 90 Jordanian men and women aged 22 to 66 years. Baseline and follow-up levels for 25-hydroxyvitamin D (25OHD), parathyroid hormone (PTH), calcium, phosphate, liver and kidney functions will be assayed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary Supplement: Omega3-FADietary Supplement: Omega3-FA 300 mg of omega3-FA once daily for 8 weeks

Timeline

Start date
2020-11-25
Primary completion
2021-07-17
Completion
2021-12-15
First posted
2019-11-22
Last updated
2022-02-24

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04174625. Inclusion in this directory is not an endorsement.